Lingvistică Extracţie Securitate inflammatory bowel disease and tumoral markers Precursor se bazează comerciant
Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies - ScienceDirect
Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia - The Lancet Gastroenterology & Hepatology
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease - eBioMedicine
Mucosal biomarkers in inflammatory bowel disease: Key pathogenic players or disease predictors?
Cytokines in inflammatory bowel disease | Nature Reviews Immunology
Tumor Markers - For Cancer Diagnosis and Prognosis - Antigens and Antibodies as Tumor Markers
Nonenzymatic tumor markers of colorectal cancer applied in routine... | Download Table
Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions | Nature Communications
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management - Gastroenterology
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
IJMS | Free Full-Text | Factor XIII-A in Diseases: Role Beyond Blood Coagulation | HTML
Frontiers | miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis
IJMS | Free Full-Text | Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer | HTML
Other Markers - MBL
Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity | Nature Communications
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review - Gastroenterology
Inflammatory Bowel Disease | NEJM
Frontiers | Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives | Anticancer Research
PDF] Tumor markers in clinical practice: General principles and guidelines | Semantic Scholar
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? | ACS Pharmacology & Translational Science
Frontiers | New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestina
Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With
Frontiers | Serum Biomarkers for Inflammatory Bowel Disease